Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol.

Neurobiol Aging. 2017 Oct 6;61:177-186. doi: 10.1016/j.neurobiolaging.2017.09.025.
[Epub ahead of print]

Abstract

PM 2 site 207This study was designed to test our hypothesis that an ultra-low dose of delta-9 tetrahydrocannabinol (THC) reverses age-dependent cognitive impairments in old mice and to examine the possible biological mechanisms that underlie this behavioral effect. Old female mice aged 24 months that had been injected once with 0.002 mg/kg THC (3-4 orders of magnitudes lower than doses that induce the conventional cannabinoid effects in mice) performed significantly better than vehicle-treated old mice and performed similarly to naive young mice aged 2 months, in 6 different behavioral assays that measured various aspects of memory and learning. The beneficial effect of THC lasted for at least 7 weeks. The single injection of THC increased the level of Sirtuin1, an enzyme that has been previously shown to be involved in neuroprotection and neuroplasticity, in the hippocampus and in the frontal cortex of old mice, for at least 7 weeks. Magnetic resonance imaging demonstrated a larger volume and higher tissue density in various regions of the brain of THC-treated old mice. These findings suggest that extremely low doses of THC that are devoid of any psychotropic effect and do not induce desensitization may provide a safe and effective treatment for cognitive decline in aging humans.

KEYWORDS:

Aging brain; Cannabinoids; Cognitive deficits; Magnetic resonance imaging (MRI); Sirtuin

PMID: 29107185

 

DOI: 10.1016/j.neurobiolaging.2017.09.025
twin memes II

Tags: , , , ,